Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Prostatic Neoplasms"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 30320
Tytuł:
The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance.
Autorzy:
Liu A; Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Gao Y; Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Wang Q; Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Lin W; Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Ma Z; Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Yang X; Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. .
Chen L; Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China. .
Xu D; Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Sep 19; Vol. 21 (1), pp. 641. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Clonal Evolution*/genetics
Prostatic Neoplasms*/genetics
Humans ; Male ; Androgen Antagonists ; Androgens ; Tumor Microenvironment ; East Asian People ; Prostatic Neoplasms, Castration-Resistant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers.
Autorzy:
Guzman J; Department of Urology and Pediatric Urology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, 91054, Germany.
Weigelt K; Department of Urology and Pediatric Urology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, 91054, Germany.
Neumann A; Department of Urology and Pediatric Urology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, 91054, Germany.
Tripal P; Optical Imaging Centre Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Schmid B; Optical Imaging Centre Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Winter Z; Optical Imaging Centre Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Palmisano R; Optical Imaging Centre Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Culig Z; Department of Urology, Division of Experimental Urology, Medical University of Innsbruck, Innsbruck, 6020, Austria.
Cronauer MV; Institute of Pathology, Universitätsklinikum Bonn, Universität Bonn, Bonn, 53127, Germany.
Muschler P; Promega GmbH, Walldorf, 69190, Germany.
Wullich B; Department of Urology and Pediatric Urology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, 91054, Germany.
Taubert H; Department of Urology and Pediatric Urology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany. .; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, 91054, Germany. .
Wach S; Department of Urology and Pediatric Urology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, 91054, Germany.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 19; Vol. 24 (1), pp. 346. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/pathology
Prostatic Neoplasms, Castration-Resistant*/pathology
Luciferases*
Male ; Humans ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Androgens ; Androgen Antagonists/pharmacology ; Androgen Antagonists/therapeutic use ; HEK293 Cells ; Protein Isoforms/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Overexpression of REST Represses the Epithelial-Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells.
Autorzy:
Indo S; Laboratory of Cellular and Molecular Oncology, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago 8380453, Chile.; Center for Cancer Prevention and Control (CECAN), Santiago 8380453, Chile.
Orellana-Serradell O; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago 8380453, Chile.
Torres MJ; Laboratory of Cellular and Molecular Oncology, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago 8380453, Chile.
Castellón EA; Laboratory of Cellular and Molecular Oncology, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago 8380453, Chile.; Center for Cancer Prevention and Control (CECAN), Santiago 8380453, Chile.
Contreras HR; Laboratory of Cellular and Molecular Oncology, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago 8380453, Chile.; Center for Cancer Prevention and Control (CECAN), Santiago 8380453, Chile.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 15; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/metabolism
Prostatic Neoplasms, Castration-Resistant*/pathology
Benzamides*
Nitriles*
Phenylthiohydantoin*
Male ; Humans ; Androgen Antagonists ; Transcription Factors ; Cell Line, Tumor ; Receptors, Androgen/metabolism ; Epithelial-Mesenchymal Transition/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Analysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study.
Autorzy:
Kim SC; Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.; Basic-Clinical Convergence Research Center, University of Ulsan, Ulsan, Korea.
Han S; Department of Biostatistics, Korea University College of Medicine, Seoul, Korea.
Yoon JH; Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Park S; Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.; Basic-Clinical Convergence Research Center, University of Ulsan, Ulsan, Korea.
Moon KH; Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Cheon SH; Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Park GM; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Kwon T; Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea. .
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2024 Mar; Vol. 65 (2), pp. 124-131.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Adolescent ; Adult ; Prostatectomy ; Seoul
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer.
Autorzy:
Lee JN; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim MY; Department of Radiation Oncology, Kyungpook National University Chilgok Hospital, Daegu, Korea.
Kang JH; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kang JK; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Chung JW; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Ha YS; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Choi SH; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim BS; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim HT; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim TH; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Yoo ES; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim SH; Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kwon TG; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea. .
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2024 Mar; Vol. 65 (2), pp. 132-138.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Prostatic Neoplasms, Castration-Resistant*/pathology
Male ; Humans ; Retrospective Studies ; Treatment Outcome ; Progression-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Novel hormonal therapy versus standard of care-A registry-based comparative effectiveness evaluation for mCRPC-patients.
Autorzy:
Jonéus P; Department of Statistics, Uppsala University, Uppsala, Sweden.
Johansson P; Department of Statistics, Uppsala University, Uppsala, Sweden.; Centre for Health-Economic Research, Uppsala University, Uppsala, Sweden.; YMSC, Tsinghua University, Beijing, China.
Langenskiöld S; Centre for Health-Economic Research, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 14; Vol. 19 (2), pp. e0290833. Date of Electronic Publication: 2024 Feb 14 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Prostatic Neoplasms*/pathology
Male ; Humans ; Standard of Care ; Quality of Life ; Docetaxel/therapeutic use ; Androgen Antagonists/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prostate Cancer and the Mevalonate Pathway.
Autorzy:
Guerrero-Ochoa P; Health Research Institute of Aragon Foundation, 50009 Zaragoza, Spain.
Rodríguez-Zapater S; Minimally Invasive Research Group (GITMI), Faculty of Veterinary Medicine, University of Zaragoza, 50009 Zaragoza, Spain.
Anel A; Department of Biochemistry and Molecular and Cellular Biology, Faculty of Sciences, University of Zaragoza, 50009 Zaragoza, Spain.
Esteban LM; Department of Applied Mathematics, Escuela Universitaria Politécnica de La Almunia, Institute for Biocomputation and Physic of Complex Systems, Universidad de Zaragoza, 50100 La Almunia de Doña Godina, Spain.
Camón-Fernández A; Health Research Institute of Aragon Foundation, 50009 Zaragoza, Spain.
Espilez-Ortiz R; Health Research Institute of Aragon Foundation, 50009 Zaragoza, Spain.; Department of Urology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.; Area of Urology, Department of Surgery, Faculty of Medicine, University of Zaragoza, 50009 Zaragoza, Spain.
Gil-Sanz MJ; Health Research Institute of Aragon Foundation, 50009 Zaragoza, Spain.; Department of Urology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.
Borque-Fernando Á; Health Research Institute of Aragon Foundation, 50009 Zaragoza, Spain.; Department of Applied Mathematics, Escuela Universitaria Politécnica de La Almunia, Institute for Biocomputation and Physic of Complex Systems, Universidad de Zaragoza, 50100 La Almunia de Doña Godina, Spain.; Department of Urology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.; Area of Urology, Department of Surgery, Faculty of Medicine, University of Zaragoza, 50009 Zaragoza, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 10; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prostatic Neoplasms, Castration-Resistant*/pathology
Prostatic Neoplasms*/metabolism
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Male ; Humans ; Mevalonic Acid ; Receptors, Androgen/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCH.
Autorzy:
Guerrios-Rivera L; Urology Section, Surgery Department, Veterans Administration Caribbean Healthcare System, San Juan, Puerto Rico.; University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Janes JL; Section of Urology, Division of Surgery, Durham VA Health Care System, Durham, North Carolina, USA.
De Hoedt AM; Section of Urology, Division of Surgery, Durham VA Health Care System, Durham, North Carolina, USA.
Klaassen Z; Department of Surgery, Section of Urology, Augusta University - Medical College of Georgia, Augusta, Georgia, USA.; Charlie Norwood VA Medical Center, Augusta, Georgia, USA.
Terris MK; Department of Surgery, Section of Urology, Augusta University - Medical College of Georgia, Augusta, Georgia, USA.; Charlie Norwood VA Medical Center, Augusta, Georgia, USA.
Cooperberg MR; Department of Urology, Diller Family Comprehensive Cancer Center, UCSF Helen, San Francisco, California, USA.
Amling CL; Department of Urology, Oregon Health and Science University School of Medicine, Portland, Oregon, USA.
Kane CJ; Department of Urology, UC San Diego Health System, San Diego, California, USA.; VA San Diego Healthcare System, San Diego, California, USA.
Aronson WJ; Department of Urology, UCLA Medical Center, Los Angeles, California, USA.; Wadsworth VA Medical Center, Los Angeles, California, USA.
Fowke JH; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Epidemiology, Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Freedland SJ; Section of Urology, Division of Surgery, Durham VA Health Care System, Durham, North Carolina, USA.; Center for Integrated Research in Cancer and Lifestyle, Division of Urology, Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7012.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms, Castration-Resistant*
Prostatic Neoplasms*/pathology
Male ; Humans ; Extranodal Extension ; Prostatectomy/methods ; Treatment Outcome ; Prostate-Specific Antigen ; Hispanic or Latino ; Neoplasm Recurrence, Local/surgery ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy.
Autorzy:
Guo Y; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong, 518132, China.
Wu J; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong, 518132, China.; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.
Chen L; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Liu L; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong, 518132, China.
Bi T; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Pan Y; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong, 518132, China.
Meng QF; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong, 518132, China.
Wang C; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Rao L; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong, 518132, China. .
Li Q; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Apr 18; Vol. 22 (1), pp. 192. Date of Electronic Publication: 2024 Apr 18.
Typ publikacji:
Journal Article
MeSH Terms:
NF-kappa B*/metabolism
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/pathology
Humans ; Male ; Animals ; Mice ; Androgens/therapeutic use ; Androgen Antagonists/pharmacology ; Androgen Antagonists/therapeutic use ; Immunotherapy/methods ; Tea ; Cell Line, Tumor ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Polymorphic ventricular tachycardia and cardiac arrest from abiraterone-induced hypokalemia: a case report.
Autorzy:
Mao J; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Chang AK; Department of Pharmacy, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Chin S; Department of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Preet K; David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.
Torosyan N; Department of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sarkissian S; Department of Hematology-Oncology, Memorial Care, Long Beach, CA, USA.
Ebinger J; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Apr 16; Vol. 18 (1), pp. 186. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hypokalemia*/chemically induced
Tachycardia, Ventricular*/diagnosis
Heart Arrest*/etiology
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/complications
Androstenes*
Male ; Humans ; Aged ; Iatrogenic Disease
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Non-preventable cases of breast, prostate, lung, and colorectal cancer in 2050 in an elimination scenario of modifiable risk factors.
Autorzy:
Palshof FK; Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark. .; Department of Breast Surgery, Gentofte Hospital, Hellerup, Denmark. .
Mørch LS; Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Køster B; Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Engholm G; Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Storm HH; Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Andersson TM; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Kroman N; Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.; Department of Breast Surgery, Gentofte Hospital, Hellerup, Denmark.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 13; Vol. 14 (1), pp. 8577. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/prevention & control
Colorectal Neoplasms*/epidemiology
Colorectal Neoplasms*/prevention & control
Male ; Humans ; Aged ; Prostate ; Risk Factors ; Lung
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Advantage of whole-mount histopathology in prostate cancer: current applications and future prospects.
Autorzy:
Duan L; Department of Urology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China.; Shanghai Genitourinary Cancer Institute, 200032, Shanghai, China.
Liu Z; Department of Urology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China.; Shanghai Genitourinary Cancer Institute, 200032, Shanghai, China.
Wan F; Department of Urology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China. .; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China. .; Shanghai Genitourinary Cancer Institute, 200032, Shanghai, China. .
Dai B; Department of Urology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China. .; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China. .; Shanghai Genitourinary Cancer Institute, 200032, Shanghai, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 11; Vol. 24 (1), pp. 448. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Artificial Intelligence*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/therapy
Prostatic Neoplasms*/pathology
Male ; Humans ; Magnetic Resonance Imaging/methods ; Prostate/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer.
Autorzy:
Fredman E; Department of Radiation Oncology, Davidoff Cancer Center, Rabin Medical Center, 39 Ze'ev Jabotinsky St, Petah Tikvah, Israel. .
Icht O; Department of Radiation Oncology, Davidoff Cancer Center, Rabin Medical Center, 39 Ze'ev Jabotinsky St, Petah Tikvah, Israel.
Moore A; Department of Radiation Oncology, Davidoff Cancer Center, Rabin Medical Center, 39 Ze'ev Jabotinsky St, Petah Tikvah, Israel.
Bragilovski D; Department of Radiation Oncology, Davidoff Cancer Center, Rabin Medical Center, 39 Ze'ev Jabotinsky St, Petah Tikvah, Israel.
Kindler J; Department of Radiation Oncology, Davidoff Cancer Center, Rabin Medical Center, 39 Ze'ev Jabotinsky St, Petah Tikvah, Israel.
Golan S; Department of Urology, Rabin Medical Center, 39 Ze'ev Jabotinsky St, Petah Tikvah, Israel.
Limon D; Department of Radiation Oncology, Davidoff Cancer Center, Rabin Medical Center, 39 Ze'ev Jabotinsky St, Petah Tikvah, Israel.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 431. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/pathology
Radiosurgery*/adverse effects
Radiosurgery*/methods
Male ; Humans ; Quality of Life ; Prospective Studies ; Progression-Free Survival ; Disease Progression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prostatic Fossa Pseudoaneurysm After Robot-Assisted Radical Prostatectomy (RARP): A Case Report.
Autorzy:
Rodrigues VMA; Department of Urology, São João University Hospital (CHUSJ), Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal.
Silva C; Department of Urology, São João University Hospital (CHUSJ), Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal.
Dias N; Department of Urology, São João University Hospital (CHUSJ), Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal.
Teixeira de Sousa J; Department of Urology, São João University Hospital (CHUSJ), Porto, Portugal.
Morgado LA; Department of Urology, São João University Hospital (CHUSJ), Porto, Portugal.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Apr 03; Vol. 25, pp. e942746. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Robotics*
Aneurysm, False*/diagnostic imaging
Aneurysm, False*/etiology
Aneurysm, False*/therapy
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Middle Aged ; Hematuria/etiology ; Hematuria/surgery ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Lapatinib antitumor effect is associated with PI3K and MAPK pathway: An analysis in human and canine prostate cancer cells.
Autorzy:
Fonseca-Alves CE; Department of Veterinary Surgery and Animal Reproduction, São Paulo State University-UNESP, Botucatu-SP, Brazil.; Institute of Health Sciences, Paulista University-UNIP, Bauru-SP, 17048-290, Brazil.
Leis-Filho AF; Department of Veterinary Surgery and Animal Reproduction, São Paulo State University-UNESP, Botucatu-SP, Brazil.
Lacerda ZA; Department of Veterinary Surgery and Animal Reproduction, São Paulo State University-UNESP, Botucatu-SP, Brazil.
de Faria Lainetti P; Department of Veterinary Surgery and Animal Reproduction, São Paulo State University-UNESP, Botucatu-SP, Brazil.
Amorim RL; Department of Veterinary Clinic, São Paulo State University-UNESP, Botucatu-SP, 18618-681, Brazil.
Rogatto SR; Department of Clinical Genetics, University Hospital of Southern Denmark, Vejle, Denmark.; Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 02; Vol. 19 (4), pp. e0297043. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Breast Neoplasms*/pathology
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/genetics
Male ; Humans ; Animals ; Dogs ; Lapatinib/pharmacology ; Lapatinib/therapeutic use ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Receptor, ErbB-2/metabolism ; Quinazolines/pharmacology ; Quinazolines/therapeutic use ; Apoptosis ; Cell Line, Tumor ; Drug Resistance, Neoplasm
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.
Autorzy:
Ramakrishnan S; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
Cortes-Gomez E; Department of Bioinformatics and Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.; Department of Biostatistics, SUNY University at Buffalo, Kimball Tower, Buffalo, NY, 14214, USA.
Athans SR; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
Attwood KM; Department of Bioinformatics and Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
Rosario SR; Department of Bioinformatics and Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
Kim SJ; Department of Pharmaceutical Sciences, SUNY University at Buffalo, Buffalo, NY, 14214, USA.
Mager DE; Department of Pharmaceutical Sciences, SUNY University at Buffalo, Buffalo, NY, 14214, USA.; Enhanced Pharmacodynamics, LLC, Buffalo, NY, 14203, USA.
Isenhart EG; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
Hu Q; Department of Bioinformatics and Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
Wang J; Department of Bioinformatics and Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
Woloszynska A; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2024 Apr 02; Vol. 16 (1), pp. 52. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Receptors, Androgen*/genetics
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/pathology
Male ; Humans ; DNA Methylation ; Gene Expression Profiling ; DNA/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer.
Autorzy:
Tam KJ; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.
Liu L; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.
Hsing M; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.
Dalal K; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.
Thaper D; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
McConeghy B; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.
Yenki P; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Bhasin S; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Peacock JW; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Wang Y; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, BC, Canada.
Cherkasov A; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Rennie PS; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Gleave ME; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Ong CJ; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada. .; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 25; Vol. 14 (1), pp. 7082. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatocyte Nuclear Factor 3-alpha*/genetics
Hepatocyte Nuclear Factor 3-alpha*/metabolism
Prostatic Neoplasms, Castration-Resistant*/genetics
Prostatic Neoplasms, Castration-Resistant*/pathology
Semaphorins*/genetics
Semaphorins*/metabolism
Humans ; Male ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Mutation ; Prostate/pathology ; Transcription Factors/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses.
Autorzy:
Cui H; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhang W; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhang L; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Qu Y; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Xu Z; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Tan Z; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Yan P; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Tang M; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Yang C; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang Y; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Chen L; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Xiao C; Department of Maternal, Child and Adolescent Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Zou Y; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Liu Y; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhang L; Department of Iatrical Polymer Material and Artificial Apparatus, School of Polymer Science and Engineering, Sichuan University, Chengdu, China.
Yang Y; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Yao Y; Department of Occupational and Environmental Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Li J; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Liu Z; Department of Maternal, Child and Adolescent Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Yang C; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Jiang X; Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, and West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Zhang B; Hainan General Hospital and Hainan Affiliated Hospital, Hainan Medical University, Haikou, China; West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2024 Mar 15; Vol. 21 (3), pp. e1004362. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Mendelian Randomization Analysis*
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/genetics
Male ; Humans ; Aged ; Risk Factors ; Smoking/adverse effects ; Tobacco Smoking ; Observational Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Machine learning prediction of Gleason grade group upgrade between in-bore biopsy and radical prostatectomy pathology.
Autorzy:
Ozbozduman K; Bogazici University Physics Department, Istanbul, Turkey. .
Loc I; Bogazici University Physics Department, Istanbul, Turkey.
Durmaz S; Department of Radiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Atasoy D; Department of Radiology, University of Koc School of Medicine, Istanbul, Turkey.
Kilic M; Department of Urology, VKF American Hospital, Istanbul, Turkey.
Yildirim H; Department of Radiology, VKF American Hospital, Istanbul, Turkey.
Esen T; Department of Urology, VKF American Hospital, Istanbul, Turkey.; Department of Urology, University of Koc School of Medicine, Istanbul, Turkey.
Vural M; Department of Radiology, VKF American Hospital, Istanbul, Turkey.
Unlu MB; Faculty of Engineering, Ozyegin University, Istanbul, Turkey.; Faculty of Aviation and Aeronautical Sciences Ozyegin University, Istanbul, Turkey.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 11; Vol. 14 (1), pp. 5849. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate*/surgery
Prostate*/pathology
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Retrospective Studies ; Biopsy ; Prostatectomy ; Image-Guided Biopsy/methods ; Neoplasm Grading
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mortality reduction and cumulative excess incidence (CEI) in the prostate-specific antigen (PSA) screening era.
Autorzy:
McLaughlin PW; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.; Department of Radiation Oncology, Assarian Cancer Center, Ascension Providence Hospital, Novi, MI, USA.
Cousins MM; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. .; Department of Advanced Radiation Oncology, Self Regional Healthcare, Greenwood, SC, USA. .
Tsodikov A; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Soni PD; Department of Radiation Oncology, Dignity Health Cancer Institute, Phoenix, AZ, USA.
Crook JM; British Columbia Cancer Agency and University of British Columbia, Kelowna, BC, Canada.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 09; Vol. 14 (1), pp. 5810. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Male ; Humans ; United States/epidemiology ; Incidence ; Early Detection of Cancer ; Mass Screening/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 30320

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies